Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Ondansetron Augmentation in Treatment Resistant Obsessive Compulsive Disorder: A Preliminary Single-Blind Prospective Study

NCT00796497 is registered in ClinicalTrials.gov with Institute of Neuroscience, Florence, Italy as lead sponsor.

NCT NCT00796497
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00796497 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Ondansetron Augmentation in Treatment Resistant Obsessive Compulsive Disorder: A Preliminary Single-Blind Prospective Study
Lead sponsor
Institute of Neuroscience, Florence, Italy
Phase
Phase 4
Overall status
Completed
Start date
March 31, 2008
Completion date
December 31, 2008
Enrollment
14 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

obsessive compulsive disorder